Human Tissue Factor (TF) Chromogenic AssaySense Activity Assay Kit (Two step, Lipo)

This assay employs a quantitative chromogenic activity technique that measures the specified antigen in samples.

Cat# Size Price Qty Buy
CT1002b 96 Well Plate £402.19

Additional Information

Property Value or Rating
Manufacturer Assaypro, LLC.
Product Type AssaySense Chromogenic Activity Kits
Samples Serum, Urine, Cell Culture, Tissue Extract
Species Human
Assay Format Chromogenic Activity Assay
Product Size 96 Well Plate
Range 7.81-250 pM
Plex Number 1
Storage Refer to component labels for details
Applications Assay
Entrez Gene 2152
Omim 134390
UniProt P13726
UniGene Hs.62192
Special Notes For Research Use Only, Not To Be Used For Diagnostic Purposes
References * Sakurai K et al. (2004) Role of p38 Mitogen-Activated Protein Kinase in Thrombus Formation. J Recept Signal Transduct Res. 24(4):283-296 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Zhang X et al. (2007) Plasma Thrombomodulin, Fibrinogen, and Activity of Tissue Factor as Risk Factors for Acute Cerebral Infarction. American Journal of Clinical Pathology 128(2):287-292 
* Okuda M and Yoshida K (2008) Reagent for measuring clotting time and method for stabilizing tissue factor. European Application number: 08005295.4 and USPTO Patent Application number: 20080241941. Patent 7867771 Issued on January 11, 2011 
* Ming XF et al. (2010) Opposing and uncoupling effects of mTOR and S6K1 in the regulation of endothelial tissue factor expression. FEBS Lett. 584(1):135-140 
* White TA (2010) Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor. Thromb Res. 125(1):84-89 
* White TA et al. (2010) Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol. 43:35-45 
* Wysoczynski M et al. (2010) Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling. Mol Cancer Res. 8(5):677-690 
* Jiang WH et al. (2011) Regulatory role of RhoA/Rho kinase in the effect of fluvastatin on tumor necrosis factor-alpha induced expression of tissue factor. Afr. J. Pharm. Pharmacol. 5(12):1462-1466 
* Zhou H et al. (2011) Toll-like receptor (TLR)-4 mediates anti-beta(2) GPI/Beta(2) GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol. 163(2):189-198 
* Sanchez-Solana B et al. (2012) p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor. J Biol Chem. 287(47):39291-302 
* Yeh HH et al. (2013) Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma. PLoS One. 8(9):e75287 
* Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery.

" title="

* Sakurai K et al. (2004) Role of p38 Mitogen-Activated Protein Kinase in Thrombus Formation. J Recept Signal Transduct Res. 24(4):283-296 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Zhang X et al. (2007) Plasma Thrombomodulin, Fibrinogen, and Activity of Tissue Factor as Risk Factors for Acute Cerebral Infarction. American Journal of Clinical Pathology 128(2):287-292 
* Okuda M and Yoshida K (2008) Reagent for measuring clotting time and method for stabilizing tissue factor. European Application number: 08005295.4 and USPTO Patent Application number: 20080241941. Patent 7867771 Issued on January 11, 2011 
* Ming XF et al. (2010) Opposing and uncoupling effects of mTOR and S6K1 in the regulation of endothelial tissue factor expression. FEBS Lett. 584(1):135-140 
* White TA (2010) Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor. Thromb Res. 125(1):84-89 
* White TA et al. (2010) Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol. 43:35-45 
* Wysoczynski M et al. (2010) Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling. Mol Cancer Res. 8(5):677-690 
* Jiang WH et al. (2011) Regulatory role of RhoA/Rho kinase in the effect of fluvastatin on tumor necrosis factor-alpha induced expression of tissue factor. Afr. J. Pharm. Pharmacol. 5(12):1462-1466 
* Zhou H et al. (2011) Toll-like receptor (TLR)-4 mediates anti-beta(2) GPI/Beta(2) GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol. 163(2):189-198 
* Sanchez-Solana B et al. (2012) p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor. J Biol Chem. 287(47):39291-302 
* Yeh HH et al. (2013) Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma. PLoS One. 8(9):e75287 
* Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery.

" target="_blank">

* Sakurai K et al. (2004) Role of p38 Mitogen-Activated Protein Kinase in Thrombus Formation. J Recept Signal Transduct Res. 24(4):283-296 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Zhang X et al. (2007) Plasma Thrombomodulin, Fibrinogen, and Activity of Tissue Factor as Risk Factors for Acute Cerebral Infarction. American Journal of Clinical Pathology 128(2):287-292 
* Okuda M and Yoshida K (2008) Reagent for measuring clotting time and method for stabilizing tissue factor. European Application number: 08005295.4 and USPTO Patent Application number: 20080241941. Patent 7867771 Issued on January 11, 2011 
* Ming XF et al. (2010) Opposing and uncoupling effects of mTOR and S6K1 in the regulation of endothelial tissue factor expression. FEBS Lett. 584(1):135-140 
* White TA (2010) Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor. Thromb Res. 125(1):84-89 
* White TA et al. (2010) Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol. 43:35-45 
* Wysoczynski M et al. (2010) Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling. Mol Cancer Res. 8(5):677-690 
* Jiang WH et al. (2011) Regulatory role of RhoA/Rho kinase in the effect of fluvastatin on tumor necrosis factor-alpha induced expression of tissue factor. Afr. J. Pharm. Pharmacol. 5(12):1462-1466 
* Zhou H et al. (2011) Toll-like receptor (TLR)-4 mediates anti-beta(2) GPI/Beta(2) GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol. 163(2):189-198 
* Sanchez-Solana B et al. (2012) p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor. J Biol Chem. 287(47):39291-302 
* Yeh HH et al. (2013) Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma. PLoS One. 8(9):e75287 
* Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery.

Related Documents